FDA Changes Position on BPA

BPA
Image via Wikipedia

As a member of Better Health Network of medical bloggers, I had an opportunity to participate in a briefing on bisphenol A (BPA) in December. You can listen to the briefing read up about issues surrounding BPA here. This is an important story which will probably receive more attention as we learn more about the safety of BPA.

On Friday, the FDA changed its position regarding BPA over concerns about the chemical which is used in a wide range of consumer products from water bottles to baby bottles. The FDA is now expressing its intent to seek and fund more studies on the public health safety of BPA.

The BPA story has been a long-running controversy and provides us with a good view of the intersection of public health, scientific rigor, commercial enterprise, government regulation, the spread of memes via social media and the economic consequences of public policy.

If it turned out, on solid scientific grounds, that BPA does indeed pose a threat what would be the economic consequences of revocation and remediation? This isn’t to equate money with life or health – but it is a point about the important role that scientific rigor has in how we produce goods.

In an age of instantaneous propagation of information (either good or bad), how do we filter out the right data from the wrong? Additionally, given that public debates are necessarily human in nature (that is to say, emotional), how do we ensure that reasoning minds appropriately congregate so we achieve the clearest results?

What do you think of the FDA’s change in stance with respect to BPA? Do you think public debates on matters like BPA safety are healthy?

Reblog this post [with Zemanta]